GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verseon Corp (GREY:VERS) » Definitions » Net Income (Continuing Operations)

Verseon (Verseon) Net Income (Continuing Operations) : $-24.01 Mil (TTM As of Jun. 2019)


View and export this data going back to 2016. Start your Free Trial

What is Verseon Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Verseon's Net Income (Continuing Operations) for the six months ended in Jun. 2019 was $-12.60 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jun. 2019 was $-24.01 Mil.


Verseon Net Income (Continuing Operations) Historical Data

The historical data trend for Verseon's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verseon Net Income (Continuing Operations) Chart

Verseon Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Net Income (Continuing Operations)
Get a 7-Day Free Trial -8.18 -7.69 -19.49 -20.39 -21.57

Verseon Semi-Annual Data
Dec11 Dec12 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.84 -11.55 -10.15 -11.42 -12.60

Verseon Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jun. 2019 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-24.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Verseon  (GREY:VERS) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.


Verseon Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Verseon's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.


Verseon (Verseon) Business Description

Industry
Traded in Other Exchanges
N/A
Address
47071 Bayside Parkway, Fremont, CA, USA, 94538
Verseon Corp is a part of the healthcare sector in the United States. It is a technology-based pharmaceutical company with a computer-driven drug discovery platform. The company designs novel drug candidates that are unlikely to be found using conventional methods. It is also engaged in drug discovery programs such as the diabetic macular edema product candidates, which treat the diseases by controlled disruption of the kallikrein kinin cascade.

Verseon (Verseon) Headlines